Patent Assignment
Reel/Frame 072038/0693
Security Interest
Recorded: 2025-07-17
Pages: 16
Assignor
MADRIGAL PHARMACEUTICALS, INC.
Executed: 2025-07-17
Assignee
LSI FINANCING LLC, AS ADMINISTRATIVE AGENT
C/O BLUE OWL CAPITAL CORPORATION, 399 PARK AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(79)
Methods for Treating a Fatty Liver Disease
Application:
63/810,372 →
Methods for Treating a Fatty Liver Disease
Application:
63/805,404 →
Methods for Treating a Fatty Liver Disease
Application:
63/804,754 →
Methods for Treating a Fatty Liver Disease
Application:
63/802,904 →
Methods for Treating a Fatty Liver Disease
Application:
63/801,986 →
Methods for Treating a Fatty Liver Disease
Methods for Treating a Fatty Liver Disease
Application:
63/721,474 →
Solid Forms of 2-(3,5-Dichloro-4-((5-Isopropyl-6-Oxo-1,6-Dihydropyridazin-3-Yl)Oxy)Phenyl)-3,5-Dioxo-2,3,4,5-Tetrahydro-1,2,4-Triazine-6-Carbonitrile
Application:
18/949,309 →
Publication:
US US20250074898A1
Methods for Treating a Fatty Liver Disease
Application:
63/720,725 →
Methods for Treating a Fatty Liver Disease
Application:
63/719,257 →
Novel Thr Beta Analogs and Uses Thereof
Application:
18/837,378 →
Publication:
US US20250154130A1
Biomarkers for Treating Liver Disorders with Thr-B Agonists and Related Uses
Application:
18/748,811 →
Publication:
US US20240423992A1
Resmetirom for Reducing Liver Volume
Application:
18/695,572 →
Publication:
US US20240408102A1
Method of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof
Methods of Treating Liver Disorders or Lipid Disorders with a Thr-Beta Agonist
Application:
18/371,229 →
Publication:
US US20240156826A1
Therapeutic Combinations of Rosuvastatin and Resmetirom for the Treatment of Liver Disorders or Lipid Disorders
Methods for Preparing Pyridazinone Derivatives
Application:
18/032,895 →
Publication:
US US20240051925A1
Methods of Treating Liver Disorders or Lipid Disorders with a Thr-Beta Agonist
Methods of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof
Combination Therapies Comprising Targeted Therapeutics
Targeted Therapeutics
Methods of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof
Methods of Treating Liver Disorders or Lipid Disorders with a Thr-Beta Agonist
Combination Therapy for Treatment of Ovarian Cancer
Methods of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof
Combination Therapy of HSP90 Inhibitors with Platinum-Containing Agents
Combination Therapy of HSP90 Inhibitors and Pd-1 Inhibitors for Treating Cancer
Targeted Therapeutics
Targeted Therapeutics
Targeted Therapeutics
Method of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof
Triazole Compounds That Modulate HSP90 Activity
Method of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof
Triazole Compounds That Modulate HSP90 Activity
Pyrrole Compounds That Modulate HSP90 Activity
Triazole Compounds That Modulate HSP90 Activity
Method for Treating Proliferative Disorders Associated with Mutations in C-Met
Triazole Compounds That Modulate HSP90 Activity
Pyrrole Compounds That Modulate HSP90 Activity
Triazole Compounds That Modulate HSP90 Activity
Cancer Therapy Using a Combination of a HSP90 Inhibitory Compounds and a Egfr Inhibitor
Pyrazole Compounds That Modulate HSP90 Activity
Methods of Identifying HSP90 Inhibitors with Less Ocular Toxicity
Triazole Compounds That Modulate HSP90 Activity
Triazole Compounds That Modulate HSP90 Activity
Triazole Compounds That Modulate HSP90 Activity
Hydrazonamide Compounds That Modulate Hsp90 Activity
Method for Treating Non-Hodgkin's Lymphoma
Method for treating a B-raf associated cancer with an Hsp90 inhibitor
Triazole Compounds That Modulate HSP90 Activity
Triazole Compounds That Modulate HSP90 Activity
Il-12 Modulatory Compounds
Method for Treating Proliferative Disorders Associated with Mutations in C-Met
Method for Inhibiting Topoisomerase Ii
Triazinone and Diazinone Derivatives Useful as HSP90 Inhibitors
Il-12 Modulatory Compounds
Triazole Compounds That Modulate HSP90 Activity
Triazone Compounds That Modulate HSP90 Activity
Purine-Core Inhibitors of HSP90 and Their Use in Treating Cancer
Fused Hetrocyclic Compounds
Triazole Compounds That Modulate HSP90 Activity
Method for Treating Non-Hodgkin's Lymphoma
Heteroaryl-Hydrazone Compounds
Fused Heterocyclic Compounds
Pyridine Compounds
Triazole Compounds That Modulate HSP90 Activity
Method for Treating Proliferative Disorders with HSP90 Inhibitors
Therapeutic Compounds and Their Use in Cancer
Triazole Compounds That Modulate HSP90 Activity
Imidazole Compounds That Modulate HSP90 Activity
Pyrazole Compounds That Modulate HSP90 Activity
Il-12 Modulatory Compounds
Pyrimidine Compounds and Uses Thereof
Triazole Compounds That Modulate HSP90 Activity
Process for Preparing Trisubstituted Pyrimidine Compounds
Heteroaryl Compounds
Il-12 Modulatory Compounds
2-Substituted Heteroaryl Compounds
Disalt Inhibitors of Il-12 Production
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 21, 2018
From: PROIA, DAVID
To: SYNTA PHARMACEUTICALS CORP.
Reel/Frame 047839/0559 →
Assignment of Assignor's Interest
Apr 18, 2019
From: TAUB, REBECCA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 048924/0851 →
Assignment of Assignor's Interest
Jan 6, 2020
From: YING, WEIWEN; CHIMMANAMADA, DINESH U.; PROIA, DAVID
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 051422/0025 →
Assignment of Assignor's Interest
Jan 6, 2020
From: JAIN, NEERA; YING, WEIWEN; CHIMMANAMADA, DINESH U.; ZHANG, JUNYI
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 051422/0240 →
Assignment of Assignor's Interest
Jul 29, 2020
From: HESTER, D. KEITH, II; DUGUID, ROBERT J.
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 053342/0966 →
Assignment of Assignor's Interest
Jul 29, 2020
From: HESTER, D. KEITH, II; DUGUID, ROBERT J.; KELLY, MARTHA J.; CHASNOFF, ANNA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 053342/0941 →
Assignment of Assignor's Interest
Aug 19, 2020
From: CHOI, DUK SOON; SHU, LIANHE; WANG, PING
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 053535/0741 →
Assignment of Assignor's Interest
Feb 23, 2021
From: HESTER, D. KEITH, II; DUGUID, ROBERT J.; KELLY, MARTHA J.; CHASNOFF, ANNA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 055366/0031 →
Assignment of Assignor's Interest
Feb 23, 2021
From: CHOI, DUK SOON; SHU, LIANHE; WANG, PING
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 055366/0065 →
Assignment of Assignor's Interest
Feb 23, 2021
From: HESTER, D. KEITH, II; DUGUID, ROBERT J.
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 055366/0061 →
Assignment of Assignor's Interest
Jul 7, 2021
From: TAUB, REBECCA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 056778/0168 →
Assignment of Assignor's Interest
Apr 21, 2023
From: CONFALONE, PASQUALE N.
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 063395/0821 →
Assignment of Assignor's Interest
Apr 21, 2023
From: CURIAL GLOBAL, INC.
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 063395/0814 →
Assignment of Assignor's Interest
Apr 21, 2023
From: VELLEKOOP, A. SAMUEL
To: CURIAL GLOBAL, INC.
Reel/Frame 063395/0785 →
Assignment of Assignor's Interest
Aug 1, 2023
From: TAUB, REBECCA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 064451/0072 →
Assignment of Assignor's Interest
Sep 26, 2023
From: TAUB, REBECCA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 065032/0678 →
Assignment of Assignor's Interest
Dec 22, 2023
From: HESTER, D. KEITH, II; DUGUID, ROBERT J.
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 065942/0863 →
Assignment of Assignor's Interest
Dec 22, 2023
From: CHOI, DUK SOON; SHU, LIANHE; WANG, PING
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 065942/0852 →
Assignment of Assignor's Interest
Dec 22, 2023
From: HESTER, D. KEITH, II; DUGUID, ROBERT J.; KELLY, MARTHA J.; CHASNOFF, ANNA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 065942/0829 →
Assignment of Assignor's Interest
Apr 1, 2024
From: TAUB, REBECCA; CHIANG, EDWARD HUNG YANG
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 066962/0122 →
Assignment of Assignor's Interest
Jun 12, 2025
From: TAUB, REBECCA; LABRIOLA, DOMINIC
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 071394/0422 →
Assignment of Assignor's Interest
Nov 12, 2025
From: TAUB, REBECCA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 072882/0146 →
Assignment of Assignor's Interest
Feb 26, 2026
From: TAUB, REBECCA
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 073902/0781 →